Literature DB >> 21297842

Rubella susceptibility: a solo family physician survey.

P Bowen-Roberts.   

Abstract

Of patients seen in the office during one month, 156 were screened for rubella hemagglutination antibody (HI) after a clinical history of susceptibility was obtained. Of these, 64 (42%) believed that they had had clinical rubella and 18 (seven percent) that they had been vaccinated. When tested, 95 (63%) were found to be immune and the remaining 55 (37%) were offered vaccination.The vaccination was given to 28 patients, 22 of whom returned after three months for a repeat HI titer. Half of these (11) required a second vaccination and five of these had the vaccination in the office. Of these five, all showed no change in immunity after the second vaccination.

Entities:  

Year:  1980        PMID: 21297842      PMCID: PMC2383545     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  6 in total

1.  An evaluation of immunization against rubella.

Authors:  J Mountifield
Journal:  Prim Care       Date:  1978-12       Impact factor: 2.907

2.  Clinical manifestations of postnatal and congenital rubella.

Authors:  L Z Cooper; S Krugman
Journal:  Arch Ophthalmol       Date:  1967-04

3.  Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic.

Authors:  D M Horstmann; H Liebhaber; G L Le Bouvier; D A Rosenberg; S B Halstead
Journal:  N Engl J Med       Date:  1970-10-08       Impact factor: 91.245

4.  Rubella immunization: progress, problems and potential solutions.

Authors:  S Krugman
Journal:  Am J Public Health       Date:  1979-03       Impact factor: 9.308

Review 5.  Prevention of congenital rubella.

Authors:  J P Welch
Journal:  Can Med Assoc J       Date:  1977-07-23       Impact factor: 8.262

6.  Guide to the management of rubella problems.

Authors:  P J Middleton; R P Larke; P Lessard; T A Doran
Journal:  Can Med Assoc J       Date:  1977-03-05       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.